loading

Apogee Therapeutics Inc (APGE) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2024-03-31 2023-09-30
期間の長さ 3 か月 3 か月
Revenues
-
-
Operating Expenses
57.09%
38.18
24.30
Operating Income/Loss
57.09%
-38.18
-24.30
Income/Loss From Continuing Operations Before Tax
54.00%
-32.09
-20.84
Income/Loss From Continuing Operations After Tax
54.00%
-32.09
-20.84
Net Income/Loss
54.00%
-32.09
-20.84
Preferred Stock Dividends And Other Adjustments
-
-
Attributable To Noncontrolling Interest
-
-
Basic Average Shares
21.73%
50.19
41.23
Diluted Average Shares
21.73%
50.19
41.23
Basic Earnings Per Share
25.49%
-0.64
-0.51
Diluted Earnings Per Share
25.49%
-0.64
-0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
-
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):